WARSAW, April 15 (Reuters) - Medana Pharma, unit of drug maker Polpharma, agreed to buy 75 million new shares in insulin producer Bioton BOTN.WA for 15 million zlotys ($4.6 million), Bioton said in a statement on Wednesday. (Reporting by Adrian Krajewski; editing by Elaine Hardcastle)
Our Standards: The Thomson Reuters Trust Principles.